|
US8920775B2
(en)
*
|
2009-07-17 |
2014-12-30 |
Technical University Of Denmark |
Loading technique for preparing radionuclide containing nanoparticles
|
|
EP3578205A1
(en)
|
2010-08-06 |
2019-12-11 |
ModernaTX, Inc. |
A pharmaceutical formulation comprising engineered nucleic acids and medical use thereof
|
|
HUE069586T2
(hu)
|
2010-10-01 |
2025-03-28 |
Modernatx Inc |
Módosított nukleozidok, nukleotidok és nukleinsavak, valamint ezek felhasználása
|
|
JP2014511687A
(ja)
|
2011-03-31 |
2014-05-19 |
モデルナ セラピューティクス インコーポレイテッド |
工学操作された核酸の送達および製剤
|
|
US9464124B2
(en)
|
2011-09-12 |
2016-10-11 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
|
DK3682905T3
(da)
|
2011-10-03 |
2022-02-28 |
Modernatx Inc |
Modificerede nukleosider, nukleotider og nukleinsyrer og anvendelser deraf
|
|
HRP20220717T1
(hr)
|
2011-12-16 |
2022-07-22 |
Modernatx, Inc. |
Modificirani pripravci mrna
|
|
US9572897B2
(en)
|
2012-04-02 |
2017-02-21 |
Modernatx, Inc. |
Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
|
|
US9283287B2
(en)
|
2012-04-02 |
2016-03-15 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of nuclear proteins
|
|
US10501512B2
(en)
|
2012-04-02 |
2019-12-10 |
Modernatx, Inc. |
Modified polynucleotides
|
|
JP6189415B2
(ja)
|
2012-04-02 |
2017-08-30 |
モデルナティエックス インコーポレイテッドＭｏｄｅｒｎａＴＸ，Ｉｎｃ． |
細胞質および細胞骨格タンパク質の産生のための修飾ポリヌクレオチド
|
|
EP2922554B1
(en)
|
2012-11-26 |
2022-02-23 |
ModernaTX, Inc. |
Terminally modified rna
|
|
EP4614148A3
(en)
*
|
2013-03-15 |
2025-12-17 |
Translate Bio, Inc. |
Synergistic enhancement of the delivery of nucleic acids via blended formulations
|
|
US8980864B2
(en)
|
2013-03-15 |
2015-03-17 |
Moderna Therapeutics, Inc. |
Compositions and methods of altering cholesterol levels
|
|
JP2014227338A
(ja)
*
|
2013-05-17 |
2014-12-08 |
キヤノン株式会社 |
インドシアニングリーン含有粒子およびその製造方法
|
|
EP3024456A4
(en)
|
2013-07-26 |
2017-04-12 |
Update Pharma Inc. |
Combinatorial methods to improve the therapeutic benefit of bisantrene
|
|
EP3052106A4
(en)
|
2013-09-30 |
2017-07-19 |
ModernaTX, Inc. |
Polynucleotides encoding immune modulating polypeptides
|
|
KR20160067219A
(ko)
|
2013-10-03 |
2016-06-13 |
모더나 세라퓨틱스, 인코포레이티드 |
저밀도 지단백질 수용체를 암호화하는 폴리뉴클레오타이드
|
|
JP6251385B2
(ja)
|
2014-04-30 |
2017-12-20 |
富士フイルム株式会社 |
リポソーム組成物及びその製造方法
|
|
JP2018505224A
(ja)
*
|
2015-02-13 |
2018-02-22 |
オーピーナノ シーオー エルティーディーＯＰ Ｎａｎｏ Ｃｏ．，Ｌｔｄ． |
ナノ粒子を含む組成物並びに腫瘍を治療する方法
|
|
US10736845B2
(en)
|
2015-03-03 |
2020-08-11 |
Cureport Inc. |
Dual loaded liposomal pharmaceutical formulations
|
|
WO2016141167A1
(en)
|
2015-03-03 |
2016-09-09 |
Cureport, Inc. |
Combination liposomal pharmaceutical formulations
|
|
JP2018510859A
(ja)
*
|
2015-03-17 |
2018-04-19 |
レオン−ナノドラッグズ ゲーエムベーハー |
安定化されたボロン酸化合物を含むナノ粒子
|
|
US10918599B2
(en)
*
|
2015-04-02 |
2021-02-16 |
The Research Foundation For The State University Of New York |
Serum-stable compositions and methods for light-triggered release of materials
|
|
ES2969082T3
(es)
|
2015-09-17 |
2024-05-16 |
Modernatx Inc |
Compuestos y composiciones para la administración intracelular de agentes terapéuticos
|
|
CN111632030B
(zh)
*
|
2015-11-02 |
2023-01-17 |
富士胶片株式会社 |
包含吉西他滨或其盐的脂质体组合物的制造方法
|
|
WO2017087685A1
(en)
|
2015-11-20 |
2017-05-26 |
The Regents Of The University Of California |
Deformable nano-scale vehicles (dnvs) for trans-blood brain barrier, trans-mucosal, and transdermal drug delivery
|
|
PT3386484T
(pt)
|
2015-12-10 |
2022-08-01 |
Modernatx Inc |
Composições e métodos para entrega de agentes terapêuticos
|
|
JP6721907B2
(ja)
*
|
2015-12-18 |
2020-07-15 |
メディギア・インターナショナル株式会社 |
生体分解性腫瘍封止剤
|
|
US10799463B2
(en)
|
2015-12-22 |
2020-10-13 |
Modernatx, Inc. |
Compounds and compositions for intracellular delivery of agents
|
|
KR101630397B1
(ko)
*
|
2015-12-31 |
2016-06-24 |
한국과학기술원 |
항암제-인도시아닌 그린-리포좀 복합체를 포함하는 암 치료용 조성물
|
|
WO2017142876A1
(en)
|
2016-02-15 |
2017-08-24 |
University Of Georgia Research Foundation, Inc. |
lPA-3-LOADED LIPOSOMES AND METHODS OF USE THEREOF
|
|
MX2018013640A
(es)
|
2016-05-16 |
2019-08-01 |
Infectious Disease Res Inst |
Liposomas pegiladas y metodos de uso.
|
|
WO2018089540A1
(en)
|
2016-11-08 |
2018-05-17 |
Modernatx, Inc. |
Stabilized formulations of lipid nanoparticles
|
|
CN106474057A
(zh)
*
|
2016-12-02 |
2017-03-08 |
中国药科大学 |
一种奥沙利铂热敏长循环脂质体的蔗糖溶液制剂及其制备方法
|
|
CN110381922A
(zh)
*
|
2017-01-18 |
2019-10-25 |
淡马锡生命科学研究院有限公司 |
超稳定脂质体增加对有丝分裂细胞的靶向作用
|
|
ES3020935T3
(en)
|
2017-03-15 |
2025-05-23 |
Modernatx Inc |
Lipid nanoparticle formulation
|
|
ES2940259T3
(es)
|
2017-03-15 |
2023-05-04 |
Modernatx Inc |
Compuesto y composiciones para la administración intracelular de agentes terapéuticos
|
|
AU2018234814B2
(en)
|
2017-03-15 |
2022-06-30 |
Modernatx, Inc. |
Crystal forms of amino lipids
|
|
US12514929B2
(en)
|
2017-04-03 |
2026-01-06 |
The Regents Of The University Of California |
Deformable nano-scale vehicles (DNVS) for trans-blood brain barrier, trans-mucosal, and transdermal drug delivery
|
|
EP3638678B1
(en)
|
2017-06-14 |
2025-12-03 |
ModernaTX, Inc. |
Compounds and compositions for intracellular delivery of agents
|
|
US11786607B2
(en)
|
2017-06-15 |
2023-10-17 |
Modernatx, Inc. |
RNA formulations
|
|
US10925831B2
(en)
*
|
2017-08-28 |
2021-02-23 |
Wake Forest University |
Liposomal formulations of platinum-acridine anticancer agents and methods thereof
|
|
JP7275111B2
(ja)
|
2017-08-31 |
2023-05-17 |
モデルナティエックス インコーポレイテッド |
脂質ナノ粒子の生成方法
|
|
WO2019084290A1
(en)
*
|
2017-10-25 |
2019-05-02 |
Arizona Board Of Regents On Behalf Of The University Of Arizona |
COMPOSITIONS AND METHODS FOR THE ADMINISTRATION OF PHARMACEUTICAL AGENTS
|
|
US10606661B2
(en)
*
|
2017-12-15 |
2020-03-31 |
Rubrik, Inc. |
On-demand provisioning of customized developer environments
|
|
TWI892261B
(zh)
|
2018-06-20 |
2025-08-01 |
日商富士軟片股份有限公司 |
包含內含吉西他濱之脂質體組成物及免疫檢查點抑制劑之組合醫藥
|
|
JP7410135B2
(ja)
|
2018-09-19 |
2024-01-09 |
モデルナティエックス インコーポレイテッド |
治療薬の細胞内送達のための化合物及び組成物
|
|
JP7526168B2
(ja)
|
2018-09-19 |
2024-07-31 |
モデルナティエックス インコーポレイテッド |
Ｐｅｇ脂質及びそれらの使用
|
|
EP4509118A3
(en)
|
2018-09-19 |
2025-05-14 |
ModernaTX, Inc. |
High-purity peg lipids and uses thereof
|
|
WO2020061457A1
(en)
|
2018-09-20 |
2020-03-26 |
Modernatx, Inc. |
Preparation of lipid nanoparticles and methods of administration thereof
|
|
WO2020115171A1
(en)
*
|
2018-12-06 |
2020-06-11 |
Glaxosmithkline Biologicals Sa |
Immunogenic compositions
|
|
RU2706427C1
(ru)
*
|
2018-12-27 |
2019-11-19 |
Федеральное государственное автономное образовательное учреждение высшего образования "Национальный исследовательский технологический университет "МИСиС" |
Способ лечения онкологических заболеваний с помощью инъекций лекарственного препарата
|
|
JP7253735B2
(ja)
|
2019-07-02 |
2023-04-07 |
パナソニックＩｐマネジメント株式会社 |
通過可否判定装置、通過管理システム、通過可否判定方法、及び、コンピュータプログラム
|
|
CA3154618A1
(en)
|
2019-09-19 |
2021-03-25 |
Modernatx, Inc. |
Branched tail lipid compounds and compositions for intracellular delivery of therapeutic agents
|
|
WO2021053163A1
(en)
|
2019-09-19 |
2021-03-25 |
Danmarks Tekniske Universitet |
Immune stimulating micelle composition
|
|
US20220364139A1
(en)
*
|
2019-09-24 |
2022-11-17 |
Pataigin, Llc |
Methods for determining growth and response
|
|
CN110571005B
(zh)
*
|
2019-09-27 |
2021-01-01 |
广西科技大学 |
一种固定化金属离子-磁性脂质体及其制备方法和应用
|
|
WO2022038605A1
(en)
*
|
2020-08-20 |
2022-02-24 |
Bionanosim (Bns) Ltd |
Lipid delivery systems for delivery of oxaliplatin palmitate acetate
|
|
KR102560135B1
(ko)
|
2020-12-04 |
2023-07-27 |
가톨릭대학교 산학협력단 |
표적 치료제의 효과적인 전달을 위한 다기능성 리포좀 조성물
|
|
US20240229154A9
(en)
|
2021-02-12 |
2024-07-11 |
Institut National de la Santé et de la Recherche Médicale |
Method for prognosis and treating a patient suffering from cancer
|
|
US11524023B2
(en)
|
2021-02-19 |
2022-12-13 |
Modernatx, Inc. |
Lipid nanoparticle compositions and methods of formulating the same
|
|
MX2023010414A
(es)
|
2021-03-08 |
2023-11-22 |
Eyegene Inc |
Composicion de la vacuna para prevenir el sars-cov-2.
|